---
layout: default
title: Morphology-Aware Prognostic model for Five-Year Survival Prediction in Colorectal Cancer from H&E Whole Slide Images
---

# Morphology-Aware Prognostic model for Five-Year Survival Prediction in Colorectal Cancer from H&E Whole Slide Images

**arXiv**: [2510.14800v1](https://arxiv.org/abs/2510.14800) | [PDF](https://arxiv.org/pdf/2510.14800.pdf)

**ä½œè€…**: Usama Sajjad, Abdul Rehman Akbar, Ziyu Su, Deborah Knight, Wendy L. Frankel, Metin N. Gurcan, Wei Chen, Muhammad Khalid Khan Niazi

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºPRISMæ¨¡å‹ä»¥é¢„æµ‹ç»“ç›´è‚ ç™Œäº”å¹´ç”Ÿå­˜ç‡ï¼Œæ•´åˆå½¢æ€å­¦è¿ç»­å˜å¼‚è°±**

**å…³é”®è¯**: `ç»“ç›´è‚ ç™Œé¢„åé¢„æµ‹` `å½¢æ€å­¦AIæ¨¡å‹` `å…¨åˆ‡ç‰‡å›¾åƒåˆ†æ` `ç”Ÿå­˜åˆ†æ` `å¯è§£é‡Šäººå·¥æ™ºèƒ½`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. æ ¸å¿ƒé—®é¢˜ï¼šç°æœ‰AIæ¨¡å‹å¿½è§†å™¨å®˜ç‰¹å¼‚æ€§å½¢æ€æ¨¡å¼ï¼Œå½±å“ç»“ç›´è‚ ç™Œé¢„åé¢„æµ‹å‡†ç¡®æ€§ã€‚
2. æ–¹æ³•è¦ç‚¹ï¼šå¼€å‘PRISMæ¨¡å‹ï¼ŒåŸºäºå½¢æ€å­¦è¿ç»­å˜å¼‚è°±è¡¨å¾è¡¨å‹å¤šæ ·æ€§ï¼Œå¢å¼ºå¯è§£é‡Šæ€§ã€‚
3. å®éªŒæˆ–æ•ˆæœï¼šåœ¨424æ‚£è€…æ•°æ®ä¸Šè®­ç»ƒï¼ŒAUCè¾¾0.70ï¼Œå‡†ç¡®ç‡68.37%ï¼Œä¼˜äºç°æœ‰æ–¹æ³•ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Colorectal cancer (CRC) remains the third most prevalent malignancy globally,
> with approximately 154,000 new cases and 54,000 projected deaths anticipated
> for 2025. The recent advancement of foundation models in computational
> pathology has been largely propelled by task agnostic methodologies that can
> overlook organ-specific crucial morphological patterns that represent distinct
> biological processes that can fundamentally influence tumor behavior,
> therapeutic response, and patient outcomes. The aim of this study is to develop
> a novel, interpretable AI model, PRISM (Prognostic Representation of Integrated
> Spatial Morphology), that incorporates a continuous variability spectrum within
> each distinct morphology to characterize phenotypic diversity and reflecting
> the principle that malignant transformation occurs through incremental
> evolutionary processes rather than abrupt phenotypic shifts. PRISM is trained
> on 8.74 million histological images extracted from surgical resection specimens
> of 424 patients with stage III CRC. PRISM achieved superior prognostic
> performance for five-year OS (AUC = 0.70 +- 0.04; accuracy = 68.37% +- 4.75%;
> HR = 3.34, 95% CI = 2.28-4.90; p < 0.0001), outperforming existing CRC-specific
> methods by 15% and AI foundation models by ~23% accuracy. It showed
> sex-agnostic robustness (AUC delta = 0.02; accuracy delta = 0.15%) and stable
> performance across clinicopathological subgroups, with minimal accuracy
> fluctuation (delta = 1.44%) between 5FU/LV and CPT-11/5FU/LV regimens,
> replicating the Alliance cohort finding of no survival difference between
> treatments.

